ESMO Faculty List · 1 Head and Neck Cancer J-P. Machiels, BE 2017-2020 2 Lung and Other Thoracic...

ESMO Faculty| Latest update 10 August 2020 1

_____________________________________________________________________________________________________

ESMO Faculty _____________________________________________________________________________________________________


FACULTY STRUCTURE 3

HEAD AND NECK CANCER 4

LUNG AND OTHER THORACIC TUMOURS 5

GASTRO-INTESTINAL TUMOURS 7

BREAST CANCER 11

GYNECOLOGIC CANCER 14

GENITOURINARY CANCER 15

SARCOMA 17

HEMATOLOGIC MALIGNANCY 19

PRINCIPLES OF CLINICAL TRIALS AND SYSTEMIC THERAPY 20

CANCER RESEARCH 22

CANCER PREVENTION 23

SUPPORTIVE AND PALLIATIVE CARE 24

CANCER GENETICS 26

CNS TUMOURS 27

NEUROENDOCRINE, ENDOCRINE NEOPLASMS AND CUP 29

MELANOMA 31

TUMOUR IMMUNOLOGY AND IMMUNOTHERAPY 32


Faculty structure

ESMO Faculty Group Coordinator Term of Office 1 Head and Neck Cancer J-P. Machiels, BE 2017-2020 2 Lung and Other Thoracic Tumours R. Dziadziuszko, PL 2019-2020 3 Gastro-Intestinal Tumours J. Taieb, FR 2020-2021 4 Breast Cancer G. Curigliano, IT 2019-2020 5 Gynecologic Cancer A. González Martín, ES 2017-2020 6 Genitourinary Cancer A. Bamias, GR 2017-2020 7 Sarcoma J. Martin Broto, ES 2017-2020 8 Hematologic Malignancy C. Buske, DE 2017-2020 9 Principles of Clinical Trials and Systemic Therapy A. Awada, BE 2017-2020

10 Cancer Research C. Caldas, UK 2019-2020 11 Cancer Prevention N. Arber, IL 2019-2020 12 Supportive and Palliative Care K. Jordan, DE 2017-2020 13 Cancer Genetics J. Balmaña, ES 2017-2020 14 CNS Tumours E. Le Rhun, FR 2017-2020 15 Neuroendocrine, Endocrine Neoplasms and CUP J. Valle, UK 2020-2021 16 Melanoma O. Michielin, CH 2017-2020 17 Tumour Immunology and Immunotherapy J. Larkin, UK 2020-2021


Head and Neck Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Jean-Pascal Machiels Belgium, Cliniques Universitaires St. Luc, Brussels 2017-2020 Diogo Alpuim Costa Portugal, Institute of Oncology Francisco Gentil, Lisbon 2017-2021 Paolo Bossi Italy, Azienda Ospedaliera Spedali Civili di Brescia 2017-2021 Jean Bourhis Switzerland, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne 2017-2021 Irene Braña Garcia Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Ana Castro Portugal, Centro Hospitalar do Porto, Porto 2017-2021 Anthony Chan Hong Kong, Prince of Wales Hospital, Sha Tin 2017-2021 Andreas Dietz Germany, University of Leipzig 2017-2021 Isabel Fonseca Portugal, University of Lisbon 2017-2021 Viktor Grünwald Germany, University Hospital Essen Westdeutsches Tumorzentrum, Essen 2017-2021 Joel Guigay France, Centre Anticancer Antoine Lacassagne, Nice 2017-2021 Kevin Harrington UK, The Institute of Cancer Research, London 2017-2021 Bhumsuk Keam Korea, Seoul National University Hospital, Seoul 2019-2023 Mariam Kukhalashvili Georgia, EVEX Medical Corporation, Kutaisi 2019-2023 Johannes A. Langendijk Netherlands, University Medical Centre Groningen 2017-2021 C. René Leemans Netherlands, VU University Medical Center, Amsterdam 2017-2021 Jean-Louis Lefebvre France, Centre Oscar Lambret, Lille 2017-2021 Lisa Licitra Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Marco Merlano Italy, Azienda Ospedaliera St. Croce e Carle, Cuneo 2017-2021 Ricardo Mesia Nin Spain, Catalan Institute of Oncology, Barcelona 2017-2021 Piero Nicolai Italy, University of Brescia 2017-2021 Sjoukje Oosting Netherlands, University Medical Center Groningen 2017-2021 Amanda Psyrri Greece, Attikon University Hospital, Athens 2017-2021 Sandra Schmitz Belgium, Saint-Luc University Hospital, Brussels 2017-2021 Christian Simon Switzerland, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne 2017-2021 Makoto Tahara Japan, National Cancer Center Hospital East, Chiba 2017-2021 Carla Van Herpen Netherlands, Radboud University Medical Center, Nijmegen 2017-2021 Jan B. Vermorken Belgium, University Hospital Antwerp (UZA), Edegem 2017-2021

https://esmo.my.salesforce.com/0013600000M7N98


Lung and other Thoracic Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Rafal Dziadziuszko Poland, Medical University of Gdansk 2019-2020 Alfredo Addeo Switzerland, Hopitaux Universitaires de Geneve 2019-2023 Paul Baas Netherlands, The Netherlands Cancer Institute (NKI), Amsterdam 2017-2021 Fabrice Barlesi France, Institut Gustave Roussy, Villejuif 2017-2021 Benjamin Besse France, Institut Gustave Roussy, Villejuif 2017-2021 Lukas Bubendorf Switzerland, University Hospital Basel, Basel 2017-2021 Antonio Calles Spain, Hospital General Universitario Gregorio Marañon, Madrid 2019-2023 Federico Cappuzzo Italy, Ospedale Santa Maria delle Croci, Ravenna 2017-2021 Fortunato Ciardiello Italy, Università della Campania Luigi Vanvitelli, Naples 2017-2021 Lucio Crinò Italy, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola 2017-2021 Tanja Cufer Slovenia, University Clinic Golnik, Golnik 2017-2021 Filippo de Marinis Italy, European Institute of Oncology, Milan 2017-2021 Dirk de Ruysscher Netherlands, Maastro Clinic, Maastricht 2017-2021 Anne-Marie Dingemans Netherlands, Erasmus MC - University Medical Center, Rotterdam 2017-2021 Wilfried Eberhardt Germany, University Hospital Essen 2017-2021 Martin Edelman USA, Fox Chase Cancer Center, Philadelphia 2017-2021 Simon Ekman Sweden, Karolinska University Hospital, Solna 2017-2021 Enriqueta Felip Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Roberto Ferrara Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2019-2023 Pier Luigi Filosso Italy, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino 2018-2022 Rabab M. Gaafar Egypt, NCI Cairo University, Cairo 2017-2021 Marina Garassino Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Pilar Garrido Lopez Spain, University Hospital Ramon and Cajal, Madrid 2017-2021 Oliver Gautschi Switzerland, Lucerne Cantonal Hospital, Lucerne 2017-2021 Ramaswamy Govindan USA, Washington University School of Medicine, St. Louis 2017-2021 Vanesa Gregorc Italy, San Raffaele Insitute, Milan 2017-2021 Cesare Gridelli Italy, Azienda Ospedaliera S. Giuseppe Moscati, Avellino 2017-2021 Dominique Grunenwald France, Tenon University Hospital, Paris 2017-2021 Pasi Jänne USA, Dana Farber Cancer Institute, Boston 2017-2021 Keith Kerr UK, Aberdeen Royal Infirmary, Aberdeen 2017-2021 Paris A. Kosmidis Greece, Hygeia Hospital, Athens 2017-2021 Cécile Le Pechoux France, Institut Gustave Roussy, Villejuif 2017-2021


Giuseppe Lo Russo Italy, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan 2019-2023 Laura Mezquita France, Institut Gustave Roussy, Villejuif 2019-2023 Tetsuya Mitsudomi Japan, Kindai University, Osaka 2017-2021 Tony S.K. Mok Hong Kong, Prince of Wales Hospital, Sha Tin 2017-2021 Floriana Morgillo Italy, University of Campania Luigi Vanvitelli, Naples 2017-2021 Giannis Mountzios Greece, University of Athens School of Medicine Clinical Therapeutics, Athens 2019-2023 Kenneth O’Byrne Australia, Princess Alexandra Hospital, Woolloongabba 2017-2021 Antonio Passaro Italy, Istituto Europeo di Oncologia, Milan 2019-2023 Luis Paz-Ares Spain, University Hospital 12 De Octubre, Madrid 2017-2021 Solange Peters Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Sara Pilotto Italy, AOU Integrata Borgo Roma Verona 2019-2023 Robert Pirker Austria, Medical University of Vienna 2017-2021 Sanjay Popat UK, Royal Marsden Hospital NHS Foundation Trust, London 2017-2021 Pieter E. Postmus Netherlands, Leiden University Medical Center, Leiden 2017-2021 Martin Reck Germany, Lung Clinic Grosshansdorf 2019-2023 Noemi Reguart Spain, Clinical and Provincial Hospital of Barcelona 2017-2021 Niels Reinmuth Germany, Lung Clinic Grosshansdorf 2017-2021 Rafael Rosell Spain, Catalan Institute of Oncology, Badalona 2017-2021 Matthias Scheffler Germany, University Hospital Cologne, Köln 2019-2023 Suresh Senan Netherlands, VU University Medical Center, Amsterdam 2017-2021 Egbert F. Smit Netherlands, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Lorenzo Spaggiari Italy, European Institute of Oncology, Milan 2018-2022 James Spicer UK, King's College London Guy's Hospital, London 2017-2021 Rolf A. Stahel Switzerland, University Hospital Zurich 2017-2021 Kostantinos Syrigos Greece, Sotiria General Hospital, Athens 2017-2021 Wan Ling Tan Singapore, National Cancer Centre Singapore 2019-2023 Johan Vansteenkiste Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Walter Weder Switzerland, Bethanien Private Clinic, Zurich 2017-2021


Gastro-Intestinal Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Julien Taieb France, European Hospital George Pompidou, Paris 2020-2021 René Adam France, University Hospital Paul Brousse, Villejuif 2017-2021 Antoine Adenis France, Institut de Cancérologie de Montpellier, Montpellier 2017-2021 Salah-Eddin Al-Batran Germany, Krankenhaus Nordwest, Frankfurt am Main 2017-2021 William Allum UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Maria Alsina Spain, Vall d'Hebron University Hospital, Barcelona 2019-2023 Guillem Argilés Spain, Vall d'Hebron University Hospital, Barcelona 2019-2023 Dirk Arnold Germany, Asklepios Klinik Altona - Asklepios Kliniken, Hamburg 2017-2021 Jorge Barriuso UK, The Christie NHS Foundation Trust, Manchester 2019-2023 Regina Beets Tan Netherlands, The Netherlands Cancer Institute, Amsterdam 2017-2021 Irit Ben-Aharon Israel, Rambam Health Care Centre, Haifa 2018-2022 Yung-Jue Bang Republic of Korea, Seoul National University Hospital, Seoul 2018-2022 Frederic Bibeau France, CHU de Caen - Hopital Cote de Nacre, Caen 2017-2021 Gyorgy Bodoky Hungary, St. László Hospital, Budapest 2017-2021 Gina Brown UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Fátima Carneiro Portugal, University of Porto 2017-2021 Alfredo Carrato Spain, Ramon y Cajal Institute for Health Research, Madrid 2017-2021 Stefano Cascinu Italy, Azienda Ospedaliero - Universitaria Policlinico di Modena 2017-2021 Andrés Cervantes Spain, University Hospital of Valencia 2017-2021 Chung Yip Chan Singapore General Hospital, Singapore 2017-2021 Ian Chau UK, The Royal Marsden NHS Foundation Trust, Sutton 2017-2021 Ann-Lii Cheng Taiwan, National Taiwan University Hospital, Taipei 2018-2022 Min Hoe Chew Singapore, Sengkang Hospital, Singapore 2017-2021 Dawn Qing Qing Chong Singapore, National Cancer Centre Singapore 2017-2021 Su Pin Choo Singapore, National Cancer Center, Singapore 2017-2021 Clarinda Wei Ling Chua Singapore, National Cancer Center, Singapore 2017-2021 Fortunato Ciardiello Italy, Università della Campania Luigi Vanvitelli, Naples 2017-2021 Thierry Conroy France, Lorraine Institute of Oncology, Vandoeuvre les Nancy 2017-2021 Anelisa Coutinho Brazil, Private practice, Salvador 2019-2023 Chiara Cremolini Italy, Azienda Toscana Nord Ovest, Pisa 2017-2021 Thierry de Baere France, Institut Gustave Roussy, Villejuif 2017-2021 Ramon Andrade De Mello Portugal, University of Algarve, Faro 2018-2022


Sarah Derks Netherlands, VU University Medical Centre, Amsterdam 2019-2023 Eduardo Diaz Rubio Spain, University Hospital San Carlos, Madrid 2017-2021 Michel Ducreux France, Institut Gustave Roussy, Villejuif 2017-2021 Elena Elez Fernandez Spain, Vall d`Hebron Institute of Oncology (VHIO), Barcelona 2018-2022 Alfredo Falcone Italy, Azienda Toscana Nord Ovest, Pisa 2017-2021 Nicola Fazio Italy, European Institute of Oncology, Milan 2017-2021 Tania Fleitas Spain, University Hospital of Valencia, Valencia 2019-2023 Jorge Gallardo Chile, Instituto Terapias Oncologicas Providencia 2018-2022 Sharlene Gill Canada, BC Cancer Agency, Vancouver 2019-2023 Robert Glynne-Jones UK, Mount Vernon Cancer Center, Northwood 2017-2021 Ullrich Graeven Germany, Kliniken Maria Hilf GmbH, Mönchengladbach 2017-2021 Thomas Gruenberger Austria, Social Medical Centre South - KFJ, Vienna Clinics, Vienna 2019-2023 Ulrich Güller Switzerland, Cantonal Hospital St. Gallen, St. Gallen 2017-2021 Volker Heinemann Germany, Ludwig Maximilians University, Munich 2017-2021 Paulo Hoff Brazil, Hospital Sirio Libanes, Sao Paulo 2019-2023 Chiun Hsu Taiwan, National Taiwan University Hospital, Taipei 2017-2021 Konstantinos Kamposioras UK, The Christie NHS Foundation Trust, Manchester 2018-2022 Yoon-Koo Kang South Korea, University of Ulsan College of Medicine, Seoul 2018-2022 Michalis Karamouzis Greece, University of Athens, Athens 2017-2021 Claus-Henning Koehne Germany, Hospital Oldenburg, Oldenburg 2017-2021 Miriam Koopman Netherlands, University Hospital Utrecht, Utrecht 2017-2021 Stefan Kubicka Germany, Kreisklinlken Reutlingen GmbH, Reutlingen 2017-2021 Roberto Labianca Italy, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo 2017-2021 Cord Langner Austria, Medical University of Graz, Graz 2017-2021 Tony Kiat Hon Lim Singapore General Hospital, Singapore 2017-2021 Florian Lordick Germany, University Hospital Leipzig 2020-2024 Fotios Loupakis Italy, Istituto Oncologico Veneto IRCCS, Padova 2017-2021 Brigette Buig Yue Ma Hong Kong, The Chinese University of Hong Kong, Shatin 2017-2021 Teresa Macarulla Spain, Vall d’Hebron Institute of Oncology (VHIO), Barcelona 2018-2022 Erika Martinelli Italy, Università degli Studi della Campania Luigi Vanvitelli, Naples 2017-2021 Kei Muro Japan, Aichi Cancer Center Hospital, Nagoya 2017-2021 Matthew C. H. Ng Singapore, National Cancer Centre, Singapore 2019-2023 Joanne Y. Y. Ngeow Singapore, National Cancer Centre, Singapore 2019-2023 Magnus Nilsson Sweden, Karolinska University Hospital, Stockholm 2019-2023 Juan Manuel O’Connor Argentina, Alexander Fleming Institute, Buenos Aires 2018-2022 Radka Obermannová Czech Republic, Masaryk Memorial Cancer Institute, Brno 2017-2021 Joao Oliveira Portugal, Portuguese Institute of Oncology of Lisbon, Lisbon 2017-2021 Pia Johanna Österlund Finland, Tampere University Hospital, Tampere 2017-2021


Manisha Palta USA, Duke University, Durham 2019-2023 Demetris Papamichael Cyprus, Bank of Cyprus Oncology Centre, Nicosia 2017-2021 Russell Petty UK, Ninewells Hospital, Dundee 2017-2021 Per Pfeiffer Denmark, Odense University Hospital, Odense 2017-2021 Gerald Prager Austria, Medical University of Vienna 2017-2021 Cornelis J.A. Punt Netherlands, Academic Medical Center, University of Amsterdam 2017-2021 Ana Cristina Raimundo Portugal, Portuguese Institute of Oncology of Porto 2017-2021 Sheela Rao UK, Royal Marsden Hospital NHS Foundation Trust, London 2019-2023 Jean-Luc Raoul France, Institute of Cancer Research in Western France, Nantes 2017-2021 Sun Young Rha Republic of Korea, Yonsei University, Seoul 2017-2021 Rachel Riechelmann Brazil, A.C. Camargo Cancer Center - Fundacao Antonio Prudente, Sao Paulo 2019-2023 Fernando Rivera Herrero Spain, Hospital Universitario Marqués de Valdecilla, Santander 2017-2021 Arnaud D. Roth Switzerland, University Hospital Geneva 2017-2021 Erika Ruíz-García Mexico, Instituto Nacional de Cancerologia, Ciudad de Mexico 2018-2022 Ramon Salazar Spain, Duran i Reynals Hospital – Catalan Institute of Oncology, Barcelona 2017-2021 Andrea Sartore Bianchi Italy, ASST Grande Ospedale Metropolitano Niguarda, Milan 2019-2023 Mark Saunders UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Werner Scheithauer Austria, Medical University of Vienna 2017-2021 Francesco Sclafani Belgium, Institute Jules Bordet, Brussels 2017-2021 Eva Segelov Australia, Monash Medical Centre, Clayton 2018-2022 Thomas Seufferlein Germany, University of Ulm 2017-2021 Matt Seymour UK, The Leeds Teaching Hospital NHS Trust, Leeds 2017-2021 Salvatore Siena Italy, ASST Grande Ospedale Metropolitano Niguarda, Milan 2017-2021 Elizabeth Smyth UK, Cambridge University Hospitals NHS Foundation Trust, Cambridge 2017-2021 Jimmy Bok Yan So Singapore, National University Cancer Institute, Singapore 2017-2021 Alberto Sobrero Italy, National Institute for Cancer Research, Genoa 2017-2021 Halfdan Sorbye Norway, Haukeland University Hospital, Bergen 2017-2021 Karen-Lise Spindler Denmark, Aarhus University Hospital, Aarhus 2020-2024 Michael Stahl Germany, Kliniken Essen Mitte, Essen 2017-2021 Naureen Starling UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2019-2023 Alexander Stein Germany, University Medical Center Hamburg-Eppendorf, Hamburg 2020-2024 Sebastian Stintzing Germany, Charité Medical University, Berlin 2017-2021 Sho Suzuki Japan, Nihon University School of Medicine, Tokyo 2017-2021 Josep Tabernero Spain, Vall d’Hebron University Hospital, Barcelona 2017-2021 David Tai Singapore, National Cancer Centre, Singapore 2019-2023 Patrick Tan Singapore, Duke-NUS Graduate Medical School, Singapore 2017-2021 Bee Huat Iain Tan Singapore, National Cancer Centre Singapore 2017-2021 Noelia Tarazona Spain, University Hospital of Valencia 2019-2023


Melissa Ching Ching Teo Singapore, National Cancer Centre Singapore 2017-2021 Jeanne Tie Australia, Peter MacCallum Cancer Centre, Melbourne 2019-2023 Giampaolo Tortora Italy, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS Rome, Rome 2017-2021 Nicola Valeri UK, The Institute of Cancer Research - North Site, Sutton 2019-2023 Juan Valle UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Eric J.D. van Cutsem Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Hanneke van Laarhoven Netherlands, University of Amsterdam 2017-2021 Marcel Verheij Netherlands, Radboud University Medical Centre Nijmegen 2017-2021 Benedikt Westphalen Germany, Ludwig Maximilians University – Grosshadern, Munich 2019-2023 Lucjan Wyrwicz Poland, Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw 2017-2021 Thomas Yau Hong Kong, The University of Hong Kong - Queen Mary Hospital, Hong Kong 2019-2023 Wei Peng Yong Singapore, National University of Singapore 2017-2021 Takayuki Yoshino Japan, National Cancer Center Hospital East, Kashiwa 2018-2022 Aziz Zaanan France, European Hospital George Pompidou, Paris 2020-2024


Breast Cancer

Name Country/Institute/City Term of Office Faculty Coordinator Giuseppe Curigliano Italy, European Institute of Oncology, Milan 2019-2020 Stefan Aebi Switzerland, Lucerne Cantonal Hospital, Lucerne 2017-2021 Frederic Amant Belgium, University Hospitals Leuven 2017-2021 Fabrice André France, Institut Gustave Roussy, Villejuif 2017-2021 Monica Arnedos France, Institut Gustave Roussy, Villejuif 2017-2021 Thomas Bachelot France, Centre Léon Bérard, Lyon 2017-2021 Carlos Barrios Brazil, Hospital Sao Lucas da PUCRS, Porto Alegre 2017-2021 Jonas Bergh Sweden, Karolinska Institute, Stockholm 2017-2021 Gouri Bhattacharyya India, G M Cancer Research Trust Palliative Care Unit - Salt Lake City Medical Center, Kolkata 2017-2021 Laura Biganzoli Italy, Nuovo Ospedale di Prato 2017-2021 José Bines Brazil, National Institute of Cancer, Rio de Janeiro 2017-2021 Hervé Bonnefoi France, Institute Bergonié, Bordeaux 2017-2021 Ana Bosch Sweden, Lund University, Lund 2019-2023 Etienne Brain France, Institut Curie - Hôpital René Huguenin, Saint-Cloud 2017-2021 Mariana Brandão Belgium, Institute Jules Bordet, Brussels 2019-2023 Fatima Cardoso Portugal, Champalimaud Cancer Center, Lisbon 2019-2023 Boon Chua Australia, Prince of Wales Hospital, Randwick 2017-2021 Giovanni Codacci-Pisanelli Italy, Policlinico Umberto I, Rome 2017-2021 Pier Franco Conte Italy, Istituto Oncologico Veneto IRCCS, Padua 2017-2021 Javier Cortes Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Carmen Criscitiello Italy, European Institute of Oncology, Milan 2017-2021 Evandro De Azambuja Belgium, Institute Jules Bordet, Brussels 2017-2021 Leticia De Mattos-Arruda Spain, Hospital Universitario Germans Trias i Pujol, Badalona 2017-2021 Suzette Delaloge France, Institut Gustave Roussy, Villejuif 2017-2021 Carsten Denkert Germany, Uniklinikum Giessen und Marburg, Marburg 2017-2021 Rebecca Dent Singapore, NCCS - National Cancer Centre Singapore 2018-2022 Serena di Cosimo Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Angelo di Leo Italy, Hospital of Prato 2017-2021 Véronique Diéras France, Centre Eugene - Marquis, Rennes 2017-2021 Peter Dubsky Switzerland, Klinik St. Anna, Luzern 2017-2021 Nagi S. El Saghir Lebanon, American University of Beirut Medical Center, Beirut 2017-2021 Alexandru Eniu Switzerland, Hôpital Riviera-Chablais, Rennaz 2017-2021


Prudence Francis Australia, Peter MacCallum Cancer Center, Melbourne 2017-2021 Sandra Ximena Franco Colombia, Clinica del Country, Bogotà 2018-2022 Karen Gelmon Canada, British Columbia Cancer Agency, Vancouver 2017-2021 Alessandra Gennari Italy, Università Degli Studi Del Piemonte Orientale, Novara 2017-2021 Luca Gianni Italy, IRCCS San Raffaele Hospital, Milan 2017-2021 Joseph Gligorov France, Tenon Hospital (AP-HP), Paris 2017-2021 Anthony Gonçalves France, Institute Paoli-Calmettes, Marseille 2017-2021 Pamela Goodwin Canada, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto 2017-2021 Nadia Harbeck Germany, Ludwig Maximilians University, Munich 2017-2021 Xichun Hu China, Fudan University Shanghai Cancer Center, Shangai 2019-2023 Michail Ignatiadis Belgium, Institute Jules Bordet, Brussels 2017-2021 Seock-Ah Im Korea, SNUH-Seoul National University Hospital, Seoul 2019-2023 Suthinee Ithimakin Thailand, Siriraj Hospital, Bangkok 2019-2023 Hiroji Iwata Japan, Aichi Cancer Center Hospital, Nagoya 2019-2023 Wolfgang Janni Germany, Ulm Medical University, Ulm 2017-2021 Guy Jerusalem Belgium, Centre Hospitalier Universitaire Sart Tilman, Liège 2017-2021 Maria João Cardoso Portugal, Champalimaud Foundation, Lisbon 2017-2021 Heikki Joensuu Finland, Helsinki University Hospital, Helsinki 2017-2021 Stephen Johnston UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Peeter Karihtala Finland, Oulu University Hospital, Oulu 2017-2021 Vesa V. Kataja Finland, Central Finland Health Care District, Jyvaskyla 2017-2021 Sung-Bae Kim Korea, Asan Medical Center - University of Ulsan College of Medicine, Seoul 2019-2023 Michael Knauer Switzerland, Cantonal Hospital St. Gallen 2017-2021 Katsumasa Kuroi Japan, Tokyo Metropolitan Health and Hospitals Corporation - Ebara Hospital, Tokyo 2019-2023 Matteo Lambertini Italy, Istituto Nazionale per la Ricerca sul Cancro, Genova 2017-2021 Barbro Linderholm Sweden, Sahlgrenska Academy and University Hospital, Gothenburg 2017-2021 Caroline Lohrisch Canada, BC Cancer Agency, Vancouver 2017-2021 Sibylle Loibl Germany, German Breast Group Forschungs GmbH, Neu-Isenburg 2017-2021 Max Mano Brazil, Hospital Sirio Libanes, São Paulo 2019-2023 Miguel Martin Jimenez Spain, Hospital General Universitario Gregorio Marañón, Madrid 2017-2021 Alexios Matikas Sweden, Karolinska University Hospital-Solna, Stockholm 2019-2023 David Miles UK, Mount Vernon Cancer Center, Northwood 2017-2021 René Munoz Bermeo Ecuador, Hospital Oncologico Solca Quito, Quito 2019-2023 Shinji Ohno Japan, Japanese Foundation for Cancer Research, Tokyo 2017-2021 Ana Mafalda Oliveira Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Olivia Pagani Switzerland, Istituto Oncologico della Svizzera Italiana, Bellinzona 2017-2021 Shani Paluch-Shimon Israel, Shaare Zedek Medical Center, Jerusalem 2017-2021 Fedro Peccatori Italy, European Institute of Oncology, Milan 2017-2021


Frédérique Penault-Llorca France, Centre Jean Perrin, Clermont-Ferrand 2017-2021 Bernhard C. Pestalozzi Switzerland, University Hospital Zurich 2017-2021 Martine Piccart Belgium, Institute Jules Bordet, Brussels 2017-2021 Jean-Yves Pierga France, Institut Curie, Paris 2017-2021 Xavier Pivot France, C. Centre Paul Strauss Centre de Lutte contre le Cancer, Strasbourg 2017-2021 Philip Poortmans France, Institut Curie, Paris 2017-2021 Joana Ribeiro Portugal, Champalimaud Foundation, Lisbon 2017-2021 Emmanouil Saloustros Greece, University Hospital of Larissa, Larissa 2019-2023 Cristina Saura Manich Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Elzbieta Senkus-Konefka Poland, Medical University of Gdansk, Gdansk 2017-2021 Peter Schmid UK, Barts Cancer Institute, London 2017-2021 Berta Sousa Portugal, Champalimaud Foundation Cancer Center, Lisbon 2017-2021 Jean-Philippe Spano France, Groupe Hospitalier Pitié-Salpêtrière, Paris 2017-2021 Benita Tan Singapore, SingHealth Duke-NUS Breast Centre, Singapore 2019-2023 Christoph Thomssen Germany, Martin Luther University of Halle (Saale) 2017-2021 Masakazu Toi Japan, Kyoto University Hospital, Kyoto 2019-2023 Tibor Tot Sweden, Central Hospital Falun, Falun 2017-2021 Dario Trapani Italy, European Institute of Oncology, Milan 2019-2023 Janice Tsang Hong Kong, Hong Kong Breast Oncology Group 2017-2021 Giuseppe Viale Italy, European Institute of Oncology, Milan 2017-2021 Anne Vincent-Salomon France, Institut Curie, Paris 2017-2021 Daniel Vorobiof South Africa, Sandton Oncology Centre, Sandton 2017-2021 Conny Vrieling Switzerland, Clinique des Grangettes, Geneva 2017-2021 Peter Vuylsteke Botswana, University of Botswana, Gaborone 2017-2021 Andrew Wardley UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Gustavo Werutsky Brazil, Latin American Cooperative Oncology Group, Porto Alegre 2019-2023 Hans Wildiers Belgium, University Hospitals Leuven 2017-2021 Binghe Xu China, Chinese Academy of Medical Sciences - National Cancer Center, Cancer Hospital, Beijing 2017-2021 Yoon Sim Yap Singapore, National Cancer Centre Singapore 2019-2023 Sophia Zackrisson Sweden, SUS Malmo - Lund University, Malmo 2017-2021 Jin Zhang China, Tianjin Medical University Cancer Institute & Hospital, Tianjin 2019-2023


Gynecologic Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Antonio González Martín Spain, Clinica Universitaria de Navarra, Madrid 2017-2020 Susana Banerjee UK, Royal Marsden Hospital NHS Foundation Trust, London 2017-2021 Nicole Concin Austria, Medical University of Innsbruck 2020-2024 Carien L. Creutzberg Netherlands, Leiden University Medical Center, Leiden 2017-2021 Karina Dahl Steffensen Denmark, Vejle Hospital, Vejle 2017-2021 Ben Davidson Norway, Oslo University Hospital - The Norwegian Radium Hospital, Oslo 2020-2024 Maria Diz Brazil, ICESP - Institute of Cancer of São Paulo 2019-2023 Rosalind M. Glasspool UK, Beatson West of Scotland Cancer Centre Gartnavel General Hospital, Glasgow 2017-2021 Charlie Gourley UK, University of Edinburgh, Edinburgh 2017-2021 Philipp Harter Germany, Kliniken Essen Mitte Evang. Huyssens-Stiftung, Essen 2020-2024 Jonathan Ledermann UK, UCL Cancer Institute - UCL - London's Global University, London 2017-2021 Domenica Lorusso Italy, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS Rome 2017-2021 Sven Mahner Germany, LMU Klinikum der Universität München, Munich 2020-2024 Christian Marth Austria, Medical University of Innsbruck, Innsbruck 2017-2021 Xavier Matias-Guiu Spain, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona 2020-2024 Mansoor Mirza Denmark, Rigshospitalet - Copenhagen University Hospital, Copenhagen 2017-2021 Ana Oaknin Spain, Vall d´Hebron Institute of Oncology, Barcelona 2017-2021 Aikou Okamoto Japan, Jikei University School of Medicine, Tokyo 2019-2023 José Alejandro Pérez Fidalgo Spain, University Hospital of Valencia, Valencia 2017-2021 Sandro Pignata Italy, Istituto Nazionale dei Tumori di Napoli, Naples 2017-2021 Andrés Maria Poveda Spain, Initia Centro Oncologico Integral - Hospital Quiron Salud Valencia, Valencia 2017-2021 Maria R. Raspollini Italy, University Hospital Careggi, Florence 2017-2021 Isabelle Ray-Coquard France, Centre Léon Bérard, Lyon 2017-2021 Cristiana Sessa Switzerland, Istituto Oncologico della Svizzera Italiana, Bellinzona 2017-2021 David Tan Singapore, NUS-National University of Singapore-National University Health System (NUHS) 2019-2023 Flora Chong Tze Malaysia, Hospital Likas, Kota Kinabalu 2019-2023


Genitourinary Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Aristotelis Bamias Greece, University of Athens 2017-2020 Laurence Albiges France, Institut Gustave Roussy, Villejuif 2017-2021 Ferran Algaba Spain, Fundacio Puigvert, Barcelona 2017-2021 Gerhardt Attard UK, University College London Cancer Institute, Sutton 2017-2021 Joaquim Bellmunt USA, Harvard Medical School, Boston 2017-2021 Axel Bex Netherlands, Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Carsten Bokemeyer Germany, University Medical Center Hamburg-Eppendorf, Hamburg 2017-2021 Petri Bono Finland, Terveystalo Helsinki Kamppi, Helsinki 2017-2021 Maurizio Brausi Italy, Ospedale Ramazzini di Carpi, Modena 2017-2021 Johann S. de Bono UK, Institute of Cancer Research, London 2017-2021 Maria de Santis Germany, Charité Medical University, Berlin 2017-2021 Ronald de Wit Netherlands, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam 2017-2021 David Dearnaley UK, Institute of Cancer Research, London 2017-2021 Tim Eisen UK, Addenbrooke’s University Hospital, Cambridge 2017-2021 Bernard Escudier France, Institut Gustave Roussy, Villejuif 2017-2021 Karim Fizazi France, Institut Gustave Roussy, Villejuif 2017-2021 Silke Gillessen Switzerland, Istituto Oncologico della Svizzera Italiana (IOSI), Bellinzona 2017-2021 Alan Horwich UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Robert A. Huddart UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Ravindran Kanesvaran Singapore, National Cancer Centre Singapore, Singapore 2017-2021 Dimitrios Kardamakis Greece, University of Patras Medical School, Patras 2017-2021 Vesa V. Kataja Finland, Central Hospital of Central Finland, Jyvaskyla 2017-2021 Christian Kollmannsberger Canada, British Columbia Cancer Agency, Vancouver 2017-2021 Jae-Lyun Lee Korea, Asan Medical Center - University of Ulsan College of Medicine, Seoul 2019-2023 Rodolfo Montironi Italy, Ospedali Riuniti Ancona 2017-2021 Nicolas Mottet France, CHU University hospital of St Etienne 2018-2022 Andrea Necchi Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Sjoukje Oosting Netherlands, University Hospital Groningen (UMCG) 2019-2023 Stephane Oudard France, European Hospital Georges Pompidou, Paris 2017-2021 Mustafa Özgüroglu Turkey, University of Istanbul 2017-2021 Camillo Porta Italy, IRCCS Pavia - Istituti Clinici Scientifici Maugeri, Pavia 2017-2021 Thomas Powles UK, St. Bartholomew’s Hospital, London 2017-2021


Daniele Santini Italy, Università Campus Bio-Medico di Roma, Rome 2017-2021 Jack Schalken Netherlands, Radbound University Medical Centre Nijmegen 2017-2021 Cora N. Sternberg USA, Weill Cornell Medicine - Belfer Research Building, New York 2017-2021 Michiel Strijbos Belgium, GZA Ziekenhuizen Campus Sint-Augustinus, Wilrijk 2017-2021 Ian Tannock Canada, Princess Margaret Cancer Center, Toronto 2017-2021 Samra Turajlic UK, Royal Marsden Hospital NHS Foundation Trust, London 2018-2022 Hendrik Van Poppel Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Hans Von der Maase Denmark, Rigshospitalet, Copenhagen 2017-2021


Sarcoma

Name Country/Institute/City Term of Office Faculty coordinator: Javier Martin Broto Spain, University Hospital Virgen del Rocio, Seville 2017-2020 Jyoti Bajpai India, Tata Memorial Centre, Mumbai 2019-2023 Sebastian Bauer Germany, University Hospital Essen Westdeutsches Tumorzentrum, Essen 2017-2021 Stefan Bielack Germany, Klinikum Stuttgart - Olgahospital, Stuttgart 2017-2021 Jean-Yves Blay France, Centre Léon Bérard, Lyon 2017-2021 Sylvie Bonvalot France, Institut Curie, Paris 2017-2021 Ioannis Boukovinas Greece, Bioclinic of Thessaloniki, Athens 2017-2021 Thomas Brodowicz Austria, Vienna General Hospital - University of Vienna 2017-2021 Paolo G. Casali Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Enrique de Álava Spain, Universidad de Salamanca (USAL), Salamanca 2017-2021 Angelo P. Dei Tos Italy, University of Padua 2017-2021 Mikael Eriksson Sweden, Skane University Hospital, Lund 2017-2021 Alexander Fedenko Russia, N. N. Blokhin Russian Cancer Research Center, Moscow 2017-2021 Andrea Ferrari Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Anna Maria Frezza Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Hans Gelderblom Netherlands, Leiden University Medical Center, Leiden 2017-2021 Francois Gouin France, Centre Leon Berard, Lyon 2019-2023 Alessandro Gronchi Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Isidro Gracia Spain, Hospital de la Santa Creu i Sant Pau, Barcelona 2020-2024 Rick Haas Netherlands, NKI-AVL - Netherlands Cancer Institute, Amsterdam 2020-2024 Peter Hohenberger Germany, Mannheim University Medical Center, Mannheim 2017-2021 Heikki Joensuu Finland, Helsinki University Central Hospital, Helsinki 2017-2021 Robin Jones UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2020-2024 Bernd Kasper Germany, University Medical Centre Mannheim, Mannheim 2020-2024 Akira Kawai Japan, National Cancer Center Hospital, Tokyo 2019-2023 Axel Le Cesne France, Institut Gustave Roussy, Villejuif 2017-2021 Ofer Merimsky Israel, Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv 2017-2021 Christina Messiou UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2020-2024 Michael Montemurro Switzerland, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne 2017-2021 Peter Reichardt Germany, Helios Hospital Berlin-Buch, Berlin 2017-2021 Silvia Stacchiotti Italy, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan 2020-2024 Kirsten Sundby Hall Norway, Oslo University Hospital, Oslo 2017-2021


Winette van der Graaf Netherlands, NKI-AVL - Netherlands Cancer Institute, Amsterdam 2017-2021 Jeremy Whelan UK, University College London Hospital UCLH NHS Foundation Trust, London 2017-2021


Hematologic Malignancy

Name Country/Institute/City Term of Office Faculty Coordinator: Christian Buske Germany, University of Ulm 2017-2020 Igor Aurer Croatia, University Hospital Zagreb 2017-2021 Johanna W. Baars Netherlands, Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Elias Campo Spain, Clinical and Provincial Hospital of Barcelona, Barcelona 2017-2021 George Canellos USA, Dana Farber Cancer Institute, Boston 2017-2021 Meletios A. Dimopoulos Greece, Alexandra Hospital, Athens 2017-2021 Martin Dreyling Germany, Ludwig Maximilians University, Munich 2017-2021 Martin F. Fey Switzerland, University Hospital of Bern 2017-2021 Michele Ghielmini Switzerland, Istituto Oncologico Svizzera Italiana, Bellinzona 2017-2021 John Goodlad UK, Cancer Center Western General Hospital, Edinburgh 2017-2021 Michael Hallek Germany, University Hospital Cologne, Cologne 2017-2021 Eva K. Kimby Sweden, Karolinska University Hospital, Stockholm 2017-2021 Marco Ladetto Italy, Presidio Ospedaliero Civile SS. Antonio e Biagio, Alessandria 2017-2021 Steven Le Gouill France, CHU de Nantes 2017-2021 Armando Lopez-Guillermo Spain, Clinical and Provincial Hospital of Barcelona 2017-2021 Markus Manz Switzerland, University Hospital Zurich 2017-2021 Uwe Platzbecker Germany, University Hospital Leipzig 2017-2021 John Radford UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Tadeusz Robak Poland, Koppernik Memory Hospital Lodz, Lodz 2017-2021 Jesus San-Miguel Spain, University of Navarra, Pamplona 2017-2021 Umberto Vitolo Italy, IRCCS - Istituto di Candiolo - FPO, Torino 2017-2021 Jan Walewski Poland, Maria Skłodowska-Curie Institute of Oncology, Warsaw 2017-2021 Emanuele Zucca Switzerland, Istituto Oncologico Svizzera Italiana, Bellinzona 2017-2021


Principles of Clinical Trials and Systemic Therapy

Name Country/Institute/City Term of Office Faculty Coordinator: Ahmad Awada Belgium, Institute Jules Bordet, Brussels 2017-2020 Steiner Aamdal Norway, Oslo University Hospital - The Norwegian Radium Hospital, Oslo 2017-2021 Alex A. Adjei USA, Mayo Clinic, Rochester 2017-2021 Guillem Argilés Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Dirk Arnold Germany, Asklepios Klinik Altona - Asklepios Kliniken, Hamburg 2017-2021 Udai Banerji UK, The Royal Marsden Hospital - NHS Foundation Trust, Sutton 2017-2021 Yazid Belkacémi France, Henri Mondor University Hospital, Creteil 2017-2021 Jean-Yves Blay France, Centre Leon Berard, Lyon 2017-2021 Emiliano Calvo Spain, Madrid Norte Sanchinarro University Hospital, Madrid 2017-2021 Fatima Cardoso Portugal, Champalimaud Cancer Center, Lisbon 2017-2021 Ana Carneiro Sweden, Skåne University Hospital, Skane 2019-2023 Thomas Cerny Switzerland, Kantonsspital St. Gallen 2017-2021 Sarah Coupland UK, University of Liverpool 2017-2021 Urania Dafni Greece, University of Athens 2017-2021 Gilberto De Castro Jr. Brazil, ICESP - Institute of Cancer of São Paulo 2019-2023 Christian Dittrich Austria, Angewandte Krebsforschung – Institution für Translationale Forschung Wien, Vienna 2017-2021 Vincent Donckier Belgium, Institute Jules Bordet, Brussels 2017-2021 Nadia Harbeck Germany, Ludwig Maximilians University (LMU), Munich 2017-2021 Peter Hohenberger Germany, Mannheim University Medical Center, Mannheim 2017-2021 Filip Janku USA, MD Anderson Cancer Center, Houston 2017-2021 Ulrich Keilholz Germany, Charité Campus Benjamin Franklin, Berlin 2017-2021 Denis Lacombe Belgium, European Organisation for Cancer Research and Treatment, Brussels 2017-2021 Paul Morten Mau-Sorensen Denmark, Rigshospitalet, Copenhagen 2017-2021 Mahesh Parmar UK, Institute of Clinical Trials and Methodology, London 2017-2021 Patrick Pauwels Belgium, Antwerp University Hospital (UZA), Edegem 2017-2021 Nicolas Penel France, Centre Oscar Lambret, Lille 2017-2021 Eric Raymond France, Hospital Saint Louis AP-HP, Paris 2017-2021 Christoph Roecken Germany, UK-SH, Campus Kiel, Kiel 2017-2021 Piotr Rutkowski Poland, Maria Skłodowska-Curie Institute of Oncology, Warsaw 2017-2021 Gilberto Schwartsmann Brazil, Hospital de Clinicas de Porto Alegre, Porto Alegre 2017-2021 Alberto Sobrero Italy, National Institute for Cancer Research, Genoa 2017-2021 Josep Tabernero Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021


Ian Tannock Canada, Princess Margaret Cancer Center, Toronto 2017-2021 Margaret Tempero USA, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco 2017-2021 Marcel Verheij Netherlands, Radboud University Medical Centre, Nijmegen 2017-2021


Cancer Research

Name Country/Institute/City Term of Office Faculty Coordinator: Carlos Caldas UK, University of Cambridge 2019-2020 Alberto Bardelli Italy, IRCCS - Istituto di Candiolo - FPO, Torino 2017-2021 Caroline Dive UK, Cancer Research UK Manchester Institute, Manchester 2017-2021 Reinhard Dummer Switzerland, University Hospital Zurich 2017-2021 Keith Flaherty USA, Massachusetts General Hospital, Boston 2017-2021 Carlos Gomez-Roca France, Institut Universitaire du Cancer – Toulouse - Oncopole, Toulouse 2019-2023 Richard Marais UK, Cancer Research UK Manchester Institute, Manchester 2019-2023 Elisa Onesti Belgium, Centre Hospitalier Universitaire Sart Tilman, Liège 2019-2023 Marco A. Pierotti Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Eli Pikarsky Israel, The Hebrew University of Jerusalem 2017-2021 Jorge Reis-Filho USA, Memorial Sloan-Kettering Can, New York 2017-2021 Caroline Robert France, Institut Gustave Roussy, Villejuif 2017-2021 Jordi Rodon USA, The University of Texas M. D. Anderson Cancer Center, Houston 2017-2021 Joan Seoane Spain, Vall d’Hebron Institute of Oncology, Barcelona 2017-2021 Charles Swanton UK, Francis Crick Institute, London 2017-2021 Giampaolo Tortora Italy, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS Rome, Rome 2017-2021 Joannes H. Van Krieken Netherlands, Radboud University Medical Center, Nijmegen 2017-2021 Emmy Verschuren Finland, Institute for Molecular Medicine Finland, Helsinki 2017-2021 Christof von Kalle Germany, National Center for Tumor Diseases, Heidelberg 2017-2021


Cancer Prevention

Name Country/Institute/City Term of Office Faculty Coordinator: Nadir Arber Israel, Tel Aviv Sourasky Medical Center, Tel Aviv 2019-2020 Philippe Autier France, International Prevention Research Institute, Lyon 2017-2021 Peter Boyle France, International Prevention Research Institute, Lyon 2019-2023 Jack Cuzick UK, Queen Mary University of London, London 2017-2021 Alexandru Eniu Switzerland, Riviera-Chablais Hospital, Rennaz 2017-2021 Gilberto Morgan Sweden, Skane University Hospital, Skane 2019-2023 Franz Porzsolt Germany, Institute of Clinical Economics e.V., Ulm 2017-2021 Dirk Schrijvers Belgium, University Hospital, Antwerp-Middelheim, Antwerp 2017-2021 Richard Sullivan UK, Institute of Cancer Policy, London 2017-2021 Thomas Szucs Switzerland, Institute of Pharmaceutical Medicine, University of Basel 2017-2021 Miri Ziv Israel, Israel Cancer Association, Givatayim 2017-2021


Supportive and Palliative Care

Name Country/Institute/City Term of Office Faculty Coordinator: Karin Jordan Germany, University of Heidelberg 2017-2020 Matti S. Aapro Switzerland, Clinique de Genolier, Genolier 2017-2021 Jean-Jacques Body Belgium, CHU Brugmann, Brussels 2017-2021 Carsten Bokemeyer Germany, University Clinic Hamburg-Eppendorf, Hamburg 2017-2021 Snezana Bosnjak Serbia, Institute of Oncology and Radiology of Serbia, Belgrade 2017-2021 Ricardo Caponero Brazil, Clínica de Oncologia Médica, São Paulo 2017-2021 Raphael Catane Israel, Sheba Medical Center, Ramat Gan 2017-2021 Alexandre Chan USA, University of California, Irvine 2020-2024 Martin Chasen Canada, William Osler Health System - Brampton Civic Hospital, Brampton 2017-2021 Nathan I. Cherny Israel, Shaare Zedek Medical Center, Jerusalem 2017-2021 Robert Coleman UK, University of Sheffield, Sheffield 2017-2021 Jeffrey Crawford USA, SeDuke Endocrinology and Bone Densitometry Clinic, Durham 2017-2021 Mario A. Dicato Luxembourg, Centre Hospitalier de Luxembourg 2017-2021 Marie Fallon UK, Cancer Research UK, Edinburgh Centre 2017-2021 Petra Feyer Germany, Krankenhaus Neukölln, Berlin 2017-2021 Azza Adel Hassan Egypt, Medical Research Institute, Alexandria University, Alexandria 2017-2021 Jorn Herrstedt Denmark, Sjaellands University Hospital Roskilde 2017-2021 David Hui USA, The University of Texas M. D. Anderson Cancer Center, Houston 2017-2021 Yeur-Hur Lai Taiwan, National Taiwan University, Taipei 2017-2021 Lorenz Jost Switzerland, Kantonsspital, Bruderholz 2017-2021 Stein Kaasa Norway, Oslo University Hospital - The Norwegian Radium Hospital, Oslo 2017-2021 Dorothy Keefe Australia, Cancer Australia, Surry Hills 2017-2021 Alex Molasiotis Hong Kong, The Chinese University of Hong Kong, Sha Tin 2019-2023 Ian Olver Australia, University of Adelaide 2017-2021 Bernardo L. Rapoport South Africa, The Medical Oncology Centre of Rosebank, Johannesburg 2017-2021 Carla Ripamonti Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Fausto Roila Italy, Santa Maria Hospital, Terni 2017-2021 Christina Ruhlmann Denmark, Odense University Hospital, Odense 2017-2021 Tiina Saarto Finland, Helsinki University Central Hospital, Helsinki 2017-2021 Mitsue Saito Japan, Juntendo University Hospital, Tokyo 2019-2023 Dirk Schrijvers Belgium, University Hospital, Antwerp-Middelheim, Antwerp 2017-2021 Florian Scotté France, Hopital Foch, Suresnes 2017-2021


Anton Snegovoy Russian Federation, N.N. Blokhin Russian Cancer Research Center, Moscow 2017-2021 Florian Strasser Switzerland, Cantonal Hospital, St. Gallen 2017-2021 Kazuo Tamura Japan, Fukuoka University, Fukuoka 2017-2021 Simon J.P. Van Belle Belgium, Ghent University Hospital, Gent 2017-2021 Declan Walsh Ireland, Trinity College, Dublin 2017-2021 Jayne Elizabeth Wood UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Annie Young UK, University of Warwick, Coventry 2017-2021 Heinz Zwierzina Austria, Innsbruck University Hospital, Innsbruck 2017-2021


Cancer Genetics

Name Country/Institute/City Term of Office Faculty Coordinator: Judith Balmaña Spain, Vall d'Hebron University Hospital, Barcelona 2017-2020 Patrick Benusiglio France, Hospital Group Pitié-Salpêtrière - Charles Foix, Paris 2017-2021 Gabriel Capella Spain, Catalan Institute of Oncology, Barcelona 2017-2021 Raphael Catane Israel, Sheba Medical Center, Ramat Gan 2017-2021 Diana Eccles UK, University Hospital Southampton, Southampton 2017-2021 Maurizio Genuardi Italy, Università Cattolica del Sacro Cuore, Rome 2019-2023 Nicoline Hoogerbrugge Netherlands, Radboud University Medical Center, Nijmegen 2017-2021 Evgeny Imyanitov Russia, Petrov Research Institute of Oncology, St. Petersburg 2017-2021 Kyriacos Kyriacou Cyprus, The Cyprus Institute of Neurology and Genetics, Nicosia 2017-2021 Pierre Laurent-Puig France, Paris Descartes University, Paris 2017-2021 Marjolijn Ligtenberg Netherlands, Radboud University Medical Center, Nijmegen 2019-2023 Niklas Loman Sweden, Skåne's University Hospital, Malmö 2017-2021 James Mackay UK, UCL Cancer Institute - UCL - London's Global University, London 2017-2021 Lina Nuñez Argentina, Instituto Nacional del Cancer, Buenos Aires 2019-2023 Carla Oliveira Portugal, Institute for Innovation and Health Research, Porto 2017-2021 Augusto Pedrazzini Switzerland, Private Practice, Locarno 2017-2021 Violeta Serra Spain, Vall d’Hebron University Hospital, Barcelona 2017-2021 Rolf Sijmons Netherlands, University College of Groningen 2019-2023 Giorgio Stanta Italy, University of Trieste - Cattinara Hospital, Trieste 2017-2021 Sabine Tejpar Belgium, University Hospital Gasthuisberg, Leuven 2017-2021


CNS Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Emilie Le Rhun Switzerland, University Hospital Zurich 2017-2020 Brigitta Baumert Switzerland, Hospital Graubünden, Chur 2017-2021 Alba A. Brandes Italy, Ospedale Bellaria, Bologna 2017-2021 Dieta Brandsma Netherlands, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam 2020-2024 Mario Campone France, Institut de Cancérologie de L’Ouest René Gauducheau, Saint-Herblain 2017-2021 Linda Dirven Netherlands, LUMC - Universitair Medisch Centrum, Leiden 2020-2024 Jean-Sebastien Frenel France, Institut de Cancérologie de L’Ouest René Gauducheau, Saint-Herblain 2017-2021 Norbert Galldiks Germany, Neurologische Universitätsklinik Köln 2020-2024 Monika Hegi Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Roger Henriksson Sweden, Umea University, Umea 2017-2021 Ulrich Herrlinger Germany, University of Bonn Medical Center, Bonn 2020-2024 Khe Hoang-Xuan France, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris 2017-2021 Yong-Kil Hong Korea, The Catholic University of Korea, Seoul 2020-2024 Nayak Lakshmi USA, Dana Farber Cancer Institute, Boston 2020-2024 Giuseppe Lombardi Italy, Istituto Oncologico Veneto IRCCS, Padova 2020-2024 Christine Marosi Austria, Medical University of Vienna 2017-2021 Giuseppe Minniti Italy, University of Siena, Siena 2020-2024 Simone Niclou Luxembourg, Luxembourg Institute of Health, Luxembourg 2017-2021 Jeannette Parkes South Africa, University of Cape Town 2017-2021 Matthias Preusser Austria, General Hospital (AKH), Vienna 2017-2021 David Reardon USA, Dana Farber Cancer Institute, Boston 2020-2024 Michele Reni Italy, IRCCS San. Raffaele Hospital, Milan 2017-2021 Jordi Rodon USA, The University of Texas M. D. Anderson Cancer Center, Houston 2017-2021 Patrick Roth Switzerland, University Hospital Zurich 2020-2024 Martin J.B. Taphoorn Netherlands, Medical Center Haaglanden, The Hague 2017-2021 Joerg-Christian Tonn Germany, Ludwig Maximilians University - Grosshadern, Munich 2017-2021 Manuel Valiente Spain, Centro Nacional de Investigaciones Oncologicas, Madrid 2020-2024 Martin Van den Bent Netherlands, Erasmuc MC, Rotterdam 2017-2021 Andreas von Deimling Germany, University of Heidelberg, Heidelberg 2020-2024 Michael Weller Switzerland, University Hospital Zurich 2017-2021 Pieter Wesseling Netherlands, Amsterdam UMC - Vrije University Medical Centre, Amsterdam 2017-2021


Manfred Westphal Germany, University Hospital Hamburg Eppendorf, Hamburg 2017-2021 Wolfgang Wick Germany, University of Heidelberg, Heidelberg 2017-2021


Neuroendocrine, Endocrine Neoplasms and CUP

Name Country/Institute/City Term of Office Faculty Coordinator: Juan Valle UK, The Christie NHS Foundation Trust, Manchester 2020-2021 Valentina Ambrosini Italy, University of Bologna 2017-2021 Richard Baum Germany, THERANOSTICUM-DKD Clinic, Wiesbaden 2017-2021 Alfredo Berruti Italy, Azienda Ospedaliera Spedali Civili di Brescia 2017-2021 Emilio Bertani Italy, European Institute of Oncology, Milan 2020-2024 Lisa Bodei USA, Memorial Sloan Kettering Cancer Center, New York 2017-2021 Guido Bonomo Italy, European Institute of Oncology, Milan 2020-2024 Gedske Daugaard Denmark, Rigshospitalet, Copenhagen 2017-2021 Henning Dralle Germany, University Hospital Essen 2017-2021 Michel Ducreux France, Institut Gustave Roussy, Villejuif 2017-2021 Rossella Elisei Italy, University of Pisa 2017-2021 Massimo Falconi Italy, IRCCS San Raffaele Hospital, Milan 2017-2021 Nicola Fazio Italy, European Institute of Oncology, Milan 2020-2024 Diego Ferone Italy, National Institute for Cancer Research, Genoa 2017-2021 Karim Fizazi France, Institut Gustave Roussy, Villejuif 2017-2021 Andrea Frilling UK, Imperial College London, London 2017-2021 Rocio Garcia-Carbonero Spain, University Hospital 12 De Octubre, Madrid 2017-2021 Hans Gelderblom Netherlands, Leiden University Medical Center, Leiden 2017-2021 Enrique Grande Spain, Hospital Universitario Ramón y Cajal, Madrid 2017-2021 Frank A. Greco USA, Sarah Cannon Cancer Center and Research, Nashville 2017-2021 Simona Grozinski Glasberg Israel, Hadassah Medical Center, Jerusalem 2017-2021 Thorvardur Halfdanarson USA, Mayo Clinic, Rochester 2020-2024 James Howe USA, University of Iowa, Iowa City 2020-2024 Grigorios Kaltsas Greece, National University of Athens 2017-2021 Yersu Kapran Turkey, Vehbi Koc American Hospital, Istanbul 2017-2021 Angela Lamarca UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Riccardo Marconcini Italy, Azienda Toscana Nord Ovest, Pisa 2017-2021 Massimo Milione Italy, Istituto Nazionale dei Tumori di Milano - Fondazione IRCCS, Milan 2019-2023 Dermot O'Toole Ireland, St Vincent’s University Hospital, Dublin 2017-2021 Kjell Oeberg Sweden, Uppsala University Hospital, Uppsala 2017-2021 Ulrich-Frank Pape Germany, Asklepios Klinik Altona, Hamburg 2020-2024 Marianne Pavel Germany, University Hospital Erlangen 2017-2021


Nicholas Pavlidis Greece, University of Ioannina 2017-2021 George Pentheroudakis Greece, University Hospital of Ioannina 2017-2021 Marie Pierre Vullierme France, Beaujon Hospital, Clichy 2017-2021 Vikas Prasad Germany, Uniklinik Ulm 2019-2023 Rachel Riechelmann Brazil, A. C. Camargo Cancer Center - Fundacao Antonio Prudente, Sao Paulo 2020-2024 Guido Rindi Italy, Fondazione Policlinico Universitario A. Gemelli, Rome 2017-2021 Martin Schlumberger France, Institut Gustave Roussy, Villejuif 2017-2021 Eva Segelov Australia, Monash Health and Monash University, Clayton 2017-2021 Simron Singh Canada, Sunnybrook Health Sciences Centre - Odette Cancer Centre, Toronto 2020-2024 Halfdan Sorbye Norway, Haukeland University Hospital, Bergen 2017-2021 Francesca Spada Italy, European Institute of Oncology, Milan 2020-2024 Eva Tiensuu Janson Sweden, Uppsala University, Uppsala 2017-2021 Agnes Van de Wouw Netherlands, VieCuri MC, Venlo 2017-2021 Chris Verslype Belgium, University Hospitals Leuven, Leuven 2017-2021 James Yao USA, MD Anderson Cancer Center, Houston 2017-2021


Melanoma

Name Country/Institute/City Term of Office Faculty coordinator: Olivier Michielin Switzerland, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne 2017-2020 Teresa Amaral Portugal, Hospital Lusíadas, Lisboa 2019-2023 Paolo Ascierto Italy, Istituto Nazionale dei Tumori - Fondazione Pascale, Naples 2017-2021 Dimitrios Bafaloukos Greece, Metropolitan Hospital, Athens 2017-2021 Juergen Becker Germany, University Hospital of Essen, Essen 2017-2021 Christian Blank Netherlands, The Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Thomas Brenn UK, Cancer Center Western General Hospital, Edinburgh 2017-2021 Reinhard Dummer Switzerland, University Hospital Zurich 2017-2021 Alexander M.M. Eggermont Netherlands, Prinses Máxima Center, Utrecht 2017-2021 Jean Jacques Grob France, Hospital St. Marguerite, Marseille 2017-2021 Axel Hauschild Germany, University Hospital UKSH, Kiel 2017-2021 Christoph Höller Austria, Vienna General Hospital, Vienna 2017-2021 Mathilde Jalving Netherlands, University Hospital Groningen (UMCG) 2019-2023 Ulrich Keilholz Germany, Charité Medical University, Berlin 2017-2021 Celeste Lebbé France, Hospital S. Louis APHP, Paris 2017-2021 Josep Malvehy Spain, Clinical and Provincial Hospital of Barcelona 2017-2021 Ivan Marquez-Rodas Spain, Hospital General Universitario Gregorio Marañon, Madrid 2019-2023 Salvador Martin Algarra Spain, Clinica Universitaria de Navarra, Pamplona 2017-2021 Caroline Robert France, Institut Gustave Roussy, Villejuif 2017-2021 Teresa Troiani Italy, Università degli Studi della Campania Luigi Vanvitelli, Naples 2017-2021 John Wagstaff UK, South West Wales Cancer Institute, Singleton Hospital, Swansea 2017-2021


Tumour Immunology and Immunotherapy

Name Country/Institute/City Term of Office Faculty coordinator: James Larkin UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2020-2021 Victoria Atkinson Australia, Princess Alexandra Hospital, Woolloongabba 2019-2023 Kalijn Bol Denmark, Herlev Hospital - National Center for Cancer Immune Therapy, Herlev 2019-2023 Mario Colombo Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Alessandra Curioni Switzerland, University Hospital Zurich, Zurich 2017-2021 Marco Donia Denmark, Herlev Hospital - National Center for Cancer Immune Therapy, Herlev 2019-2023 Andrew Furness UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2019-2023 John Haanen Netherlands, Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam 2020-2024 Jessica Hassel Germany, National Center for Tumor Diseases - NCT, Heidelberg 2020-2024 Ulrich Keilholz Germany, Charité Medical University, Berlin 2017-2021 Alexander Knuth Qatar, National Center for Cancer Care & Research NCCCR, Doha 2017-2021 Marleen Kok Netherlands, Netherlands Cancer Institute, Amsterdam 2020-2024 Athanasios Kotsakis Greece, University Hospital of Heraklion, Heraklion 2017-2021 Evan J. Lipson USA, Johns Hopkins University, Baltimore 2018-2022 Kevin Litchfield UK, Francis Crick Institute, London 2020-2024 Alexander Marx Germany, University Medical Center, Mannheim 2017-2021 Alexander Menzies Australia, Melanoma Institute Australia, Wollstonecraft 2019-2023 Rodrigo Munhoz Brazil, Hospital Sírio LÍbanês, Sao Paulo 2019-2023 Kenneth O'Byrne Australia, Princess Alexandra Hospital, Woolloongabba 2019-2023 Kjell Oeberg Sweden, Uppsala University Hospital, Uppsala 2017-2021 Rienk Offringa Germany, German Cancer Research Center, Heidelberg 2017-2021 Naiyer Rizvi USA, Columbia University Hospital, New York 2017-2021 Emanuela Romano France, Institut Curie, Paris 2019-2023 Bettina Ryll Sweden, Melanoma Patient Network Europe MPNE , Uppsala 2020-2024 Lavinia Spain Australia, Peter MacCallum Cancer Centre, Melbourne 2020-2024 Rolf A. Stahel Switzerland, University Hospital Zurich 2017-2021 Inge Marie Svane Denmark, Herlev and Gentofte Hospital, Herlev 2020-2024 Michele Teng Australia, QIMR Berghofer Medical Research Institute, Brisbane 2019-2023 Han Chong Toh Singapore, National Cancer Centre Singapore 2019-2023 Samra Turajlic UK, The Royal Marsden Hospital - NHS Foundation Trust, London 2020-2024 Yann Vano France, European Hospital George Pompidou, Paris 2020-2024


Laurence Zitvogel France, Institut Gustave Roussy, Villejuif 2017-2021 Lotje Zuur Netherlands, The Netherlands Cancer Institute, Amsterdam 2020-2024

ESMO Faculty List · 1 Head and Neck Cancer J-P. Machiels, BE 2017-2020 2 Lung and Other Thoracic...

Documents

Transcript of ESMO Faculty List · 1 Head and Neck Cancer J-P. Machiels, BE 2017-2020 2 Lung and Other Thoracic...